PubRank

Brent A Moore

Author PubWeight™ 48.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med 2006 3.64
2 Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 2004 3.26
3 The time course and significance of cannabis withdrawal. J Abnorm Psychol 2003 2.70
4 Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007 2.38
5 Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. J Consult Clin Psychol 2006 2.15
6 A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. Am J Med 2013 1.77
7 Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Drug Alcohol Depend 2006 1.73
8 Terminal decontamination of patient rooms using an automated mobile UV light unit. Infect Control Hosp Epidemiol 2011 1.67
9 A trial of integrated buprenorphine/naloxone and HIV clinical care. Clin Infect Dis 2006 1.62
10 Delay discounting in current and former marijuana-dependent individuals. Exp Clin Psychopharmacol 2010 1.48
11 Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. Am J Addict 2008 1.45
12 Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. J Subst Abuse Treat 2007 1.38
13 Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients. Drug Alcohol Depend 2008 1.30
14 Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. J Gen Intern Med 2007 1.27
15 The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med 2006 1.21
16 Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci 2008 1.18
17 The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence. Am J Addict 2010 1.10
18 Counselors' Experiences Treating Methadone-maintained Patients with Chronic Pain: A Needs Assessment Study. J Addict Med 2008 1.08
19 Development and consequences of cannabis dependence. J Clin Pharmacol 2002 1.07
20 Pain and associated substance use among opioid dependent individuals seeking office-based treatment with buprenorphine-naloxone: a needs assessment study. Am J Addict 2013 1.04
21 A cross-study comparison of cannabis and tobacco withdrawal. Am J Addict 2005 1.02
22 Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care. J Gen Intern Med 2012 0.95
23 Comparison of fluorescent marker systems with 2 quantitative methods of assessing terminal cleaning practices. Infect Control Hosp Epidemiol 2011 0.95
24 Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sex Transm Dis 2008 0.94
25 Comparison of the microbiological efficacy of hydrogen peroxide vapor and ultraviolet light processes for room decontamination. Infect Control Hosp Epidemiol 2012 0.94
26 Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone. J Addict Med 2012 0.90
27 Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone. J Gen Intern Med 2010 0.90
28 Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. J Subst Abuse Treat 2012 0.89
29 Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians. J Addict Med 2012 0.88
30 Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients. J Acquir Immune Defic Syndr 2015 0.86
31 Personality disorders and retention in a therapeutic community for substance dependence. Am J Addict 2011 0.82
32 The feasibility and acceptability of groups for pain management in methadone maintenance treatment. J Addict Med 2014 0.80
33 Recovery and URICA stage-of-change scores in three marijuana treatment studies. J Subst Abuse Treat 2008 0.78
34 Examining the influence of clinician decision making on adherence to a clinical guideline. Psychiatr Serv 2009 0.77
35 HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment. J Addict Med 2013 0.77
36 The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine. J Addict Med 2016 0.75
37 Incorporating clinical guidelines through clinician decision-making. Implement Sci 2008 0.75
38 Multiple Sources of Prescription Payment and Risky Opioid Therapy Among Veterans. Med Care 2017 0.75